Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: May 14, 2019
Open Peer Review Period: May 17, 2019 - Jul 12, 2019
Date Accepted: Feb 22, 2020
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Sustainability of mHealth Effects on Cardiometabolic Risk Factors: Five-Year Results of a Randomized Clinical Trial

Bernabe-Ortiz A, Pauschardt J, Diez-Canseco F, Miranda JJ

Sustainability of mHealth Effects on Cardiometabolic Risk Factors: Five-Year Results of a Randomized Clinical Trial

J Med Internet Res 2020;22(4):e14595

DOI: 10.2196/14595

PMID: 32314970

PMCID: 7201320

Sustainability of mHealth effects on cardiometabolic risk factors: 5-year results of a randomized clinical trial

  • Antonio Bernabe-Ortiz; 
  • Julia Pauschardt; 
  • Francisco Diez-Canseco; 
  • J. Jaime Miranda

ABSTRACT

Background:

Long-term effect of mHealth interventions has not been documented, especially in resource-constrained settings.

Objective:

This study aimed at assessing the 5-year effect of a mHealth intervention on blood pressure levels and bodyweight in low-resource urban settings in Peru.

Methods:

After 5 years from randomisation, we attempted to contact the 212 individuals originally enrolled in the GISMAL Study in Peru. Primary outcomes were changes in systolic and diastolic blood pressure; and, in addition, hypertension incidence was also evaluated. Secondary outcome measures were changes in bodyweight and body mass index, and self-reported target behaviours. Study personnel collecting data were masked to group assignment. Linear mixed models were used to evaluate the effect of the intervention in primary and secondary outcomes in an intent-to-treat analysis.

Results:

Data from 164 (77.4%) out of 212 participants originally enrolled were available and analysed (80 in the intervention and 84 in the control group). The intervention did not result in changes in systolic (-2.54 mm Hg; 95% CI: -8.23; 3.15) or diastolic blood pressure (3.41 mm Hg; 95% CI: -0.75; 7.57) compared with the control group. The intervention reduced the risk of developing hypertension, but result was not significant (RR = 0.76; 95% CI: 0.45; 1.28). However, among secondary outcomes, those who received the intervention had a lower bodyweight (-5.42 kg; 95% CI: -10.4; -0.48) and BMI (-2.56 kg/m2; 95% CI: -4.46; -0.66). In addition, compared to controls, those who received ≥50% of the scheduled calls during the intervention had greater reductions of bodyweight (-6.23 kg; 95% CI: -11.47; -0.99) and BMI (-2.81 kg/m2; 95% CI: -4.77; -0.85).

Conclusions:

An mHealth intervention comprising motivational interview calls and SMS appears to have long-term effects on health. Although there were no effects on blood pressure levels, important reductions in bodyweight and BMI were seen five years after randomisation. Thus, mHealth appears to be a promising preventive strategy for non-communicable diseases in resource-constrained settings. Clinical Trial: N/A


 Citation

Please cite as:

Bernabe-Ortiz A, Pauschardt J, Diez-Canseco F, Miranda JJ

Sustainability of mHealth Effects on Cardiometabolic Risk Factors: Five-Year Results of a Randomized Clinical Trial

J Med Internet Res 2020;22(4):e14595

DOI: 10.2196/14595

PMID: 32314970

PMCID: 7201320

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.